|
RDH11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.6908037150456E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.61400001644319E-09 |
| Normal-vs-Stage2 |
1.48989998116633E-09 |
| Normal-vs-Stage3 |
1.73010000004137E-06 |
| Normal-vs-Stage4 |
7.20430004541583E-09 |
| Stage1-vs-Stage2 |
1.154380E-01 |
| Stage1-vs-Stage3 |
8.715000E-01 |
| Stage1-vs-Stage4 |
6.579700E-03 |
| Stage2-vs-Stage3 |
3.035400E-01 |
| Stage2-vs-Stage4 |
2.328800E-01 |
| Stage3-vs-Stage4 |
3.959900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.84079459745135E-11 |
| Normal-vs-AfricanAmerican |
3.19430000006449E-07 |
| Normal-vs-Asian |
1.658390E-03 |
| Caucasian-vs-AfricanAmerican |
5.311000E-01 |
| Caucasian-vs-Asian |
9.509000E-01 |
| AfricanAmerican-vs-Asian |
7.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67577063336921E-12 |
| Normal-vs-Female |
1.439390E-04 |
| Male-vs-Female |
7.500500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.2190000000053E-05 |
| Normal-vs-Extreme_Weight |
3.72640029944193E-10 |
| Normal-vs-Obese |
3.98820000357958E-08 |
| Normal-vs-Extreme_Obese |
1.839480E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.720600E-01 |
| Normal_Weight-vs-Obese |
9.324800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.598400E-01 |
| Extreme_Weight-vs-Obese |
5.303400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.566000E-01 |
| Obese-vs-Extreme_Obese |
5.999200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65680000052681E-07 |
| Normal-vs-Age(41-60Yrs) |
1.59880000016877E-07 |
| Normal-vs-Age(61-80Yrs) |
5.38558087015417E-12 |
| Normal-vs-Age(81-100Yrs) |
2.02469999988075E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.544610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.419000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.665800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.716300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.245600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.275600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.32279750989051E-11 |
| Normal-VS-Type2 PRCC |
5.1813000001566E-08 |
| Normal-VS-KIRP CIMP |
1.4734999997934E-08 |
| Normal-VS-Unclassified PRCC |
6.63039999571069E-08 |
| Type1 PRCC-VS-Type2 PRCC |
9.041800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.077700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.553000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.029600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.832200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.809180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30439992140907E-10 |
| Normal-vs-N1 |
1.0166000041778E-08 |
| Normal-vs-N2 |
2.41429999991993E-07 |
| N0-vs-N1 |
9.687800E-01 |
| N0-vs-N2 |
5.782300E-02 |
| N1-vs-N2 |
4.435900E-02 |
|
|
